COVID-19 Infection clinical trials
Showing 101–106 of 106 active trials. Describe your situation to see which ones you may be eligible for.
- CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
- NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
- Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
- COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
- A Study of Healthy Microbiome, Healthy Mind
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.